Jeanne Morrow, Legal Representative

Title: Jeanne Morrow: Innovator in Anthrax Immunization

Introduction

Jeanne Morrow is a distinguished legal representative and inventor based in San Diego, California. She has made significant contributions to the field of immunization, particularly in the development of antibodies against anthrax. With two patents to her name, her work focuses on innovative methods for generating human antibodies that can be used therapeutically and prophylactically.

Latest Patents

Jeanne Morrow's latest patents include groundbreaking methods for generating human antibodies specific to the anthrax toxin. One patent describes a highly efficient method utilizing recall technology, which involves human peripheral blood cells pre-exposed to anthrax toxin in a SCID mouse model. This method results in high human antibody titers, primarily of the IgG isotype, with high specificity and affinity to desired antigens. The antibodies generated can be used to prevent or treat anthrax exposure, particularly in scenarios involving bioterrorism. Additionally, her patents outline formulations and methods for preventing and treating anthrax infections, including binding agents that inhibit the assembly of the PA63 heptamer.

Career Highlights

Jeanne Morrow is currently associated with Emergent Product Development Gaithersburg Inc., where she continues to advance her research in immunization. Her innovative approaches have positioned her as a key figure in the fight against anthrax and other potential bioterrorism threats.

Collaborations

Jeanne collaborates with notable colleagues, including Angray Singh Kang and Fei Wang, who contribute to her research efforts and the development of her patented technologies.

Conclusion

Jeanne Morrow's work in the field of immunization against anthrax showcases her dedication to public health and safety. Her innovative patents and collaborative efforts highlight her significant role in advancing medical science.